Publicaciones (45) Publicaciones de FEDERICO GARCÍA GARCÍA

2023

  1. Mpox Infection and Sexually Transmitted Infections: A Cross-Sectional Study from a Secondary Hospital in the May–September 2022 International Outbreak

    AIDS Research and Human Retroviruses, Vol. 39, Núm. 11, pp. 604-609

2022

  1. Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe

    HIV Medicine, Vol. 23, Núm. 7, pp. 774-789

  2. Positive Outcomes: Validity, reliability and responsiveness of a novel person-centred outcome measure for people with HIV

    HIV Medicine, Vol. 23, Núm. 6, pp. 673-683

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Country Level Diversity of the HIV-1 Pandemic between 1990 and 2015

    Journal of Virology, Vol. 95, Núm. 2

  3. Network meta-analysis of post-exposure prophylaxis randomized clinical trials

    HIV Medicine, Vol. 22, Núm. 3, pp. 218-224

  4. Secuenciación del genoma del Sars-CoV-2 en Andalucía, metodología y estudio de las variantes

    Actualidad médica, Tomo 106, Núm. 814, pp. 291-300

2020

  1. COVID-19 y aparato digestivo: protección y manejo en la pandemia por SARS-CoV-2

    Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 5, pp. 389-396

  2. Concordance between Rapid On-Site Evaluation and Final Cytologic Diagnosis in Patients Undergoing Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Non-Small Cell Lung Cancer Staging

    American Journal of Clinical Pathology, Vol. 153, Núm. 2, pp. 190-197

  3. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  4. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  5. First national survey of the diagnosis of Helicobacter pylori infection in Clinical Microbiology Laboratories in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 410-416

  6. Fundamentos para aplicar una estrategia de cribado poblacional de la hepatitis C en España

    Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 1, pp. 64-70

  7. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

2019

  1. Eficiencia de diversas estrategias para el diagnóstico de la hepatitis C en un solo paso

    Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 1, pp. 10-16

  2. Hepatitis víricas, cuestiones actuales: los virus de las Hepatitis C y E : dos agentes emergentes

    Eirba analistas

2018

  1. Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance

    AIDS, Vol. 32, Núm. 3, pp. 327-335

2017

  1. Comparative activity of tedizolid against clinical isolates of linezolid-resistant coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 5, pp. 323-324

  2. Experiencia en práctica clínica real con los nuevos antivirales de acción directa en hepatitis crónica C

    Medicina Clinica, Vol. 149, Núm. 9, pp. 375-382

  3. Morphological and immunophenotypical differences between chronic periodontitis and peri-implantitis - a cross-sectional study

    European Journal of Oral Implantology, Vol. 10, Núm. 4, pp. 453-463